Fox Run Management L.L.C. grew its holdings in shares of The Allstate Corporation (NYSE:ALL - Free Report) by 162.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,740 shares of the insurance provider's stock after buying an additional 6,652 shares during the period. Allstate accounts for about 0.3% of Fox Run Management L.L.C.'s investment portfolio, making the stock its 24th biggest holding. Fox Run Management L.L.C.'s holdings in Allstate were worth $2,224,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the business. Kovitz Investment Group Partners LLC raised its holdings in shares of Allstate by 61.5% during the first quarter. Kovitz Investment Group Partners LLC now owns 36,914 shares of the insurance provider's stock valued at $7,644,000 after buying an additional 14,057 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its holdings in shares of Allstate by 11.1% during the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 80,155 shares of the insurance provider's stock valued at $16,598,000 after buying an additional 8,000 shares during the last quarter. Boston Partners raised its holdings in shares of Allstate by 613.9% during the first quarter. Boston Partners now owns 2,482,654 shares of the insurance provider's stock valued at $512,627,000 after buying an additional 2,134,893 shares during the last quarter. William B. Walkup & Associates Inc. raised its holdings in shares of Allstate by 3.5% during the first quarter. William B. Walkup & Associates Inc. now owns 23,948 shares of the insurance provider's stock valued at $4,959,000 after buying an additional 811 shares during the last quarter. Finally, GQG Partners LLC raised its holdings in shares of Allstate by 2.1% during the first quarter. GQG Partners LLC now owns 4,405,701 shares of the insurance provider's stock valued at $912,288,000 after buying an additional 89,185 shares during the last quarter. Institutional investors own 76.47% of the company's stock.
Allstate Price Performance
Shares of NYSE ALL traded up $2.6740 during trading on Tuesday, hitting $209.7640. The company had a trading volume of 280,355 shares, compared to its average volume of 1,728,017. The company has a market cap of $55.27 billion, a P/E ratio of 9.86, a PEG ratio of 0.84 and a beta of 0.35. The Allstate Corporation has a 52 week low of $176.00 and a 52 week high of $213.18. The business's 50-day moving average is $198.28 and its 200 day moving average is $198.62. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43.
Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share for the quarter, topping the consensus estimate of $3.20 by $2.74. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The firm had revenue of $15.05 billion for the quarter, compared to analysts' expectations of $16.59 billion. During the same period in the previous year, the company posted $1.61 EPS. The company's quarterly revenue was up 5.8% compared to the same quarter last year. Equities research analysts predict that The Allstate Corporation will post 18.74 earnings per share for the current fiscal year.
Allstate Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Investors of record on Friday, August 29th will be issued a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Friday, August 29th. Allstate's dividend payout ratio (DPR) is currently 18.81%.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on ALL shares. Raymond James Financial reaffirmed a "strong-buy" rating and set a $260.00 price target (up previously from $250.00) on shares of Allstate in a report on Monday, August 4th. Evercore ISI boosted their target price on Allstate from $227.00 to $230.00 and gave the stock an "outperform" rating in a report on Thursday, May 1st. BMO Capital Markets reissued an "outperform" rating on shares of Allstate in a report on Friday, May 16th. Morgan Stanley boosted their target price on Allstate from $235.00 to $245.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. Finally, UBS Group boosted their target price on Allstate from $230.00 to $235.00 and gave the stock a "buy" rating in a report on Wednesday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $229.33.
Get Our Latest Stock Report on ALL
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Articles

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.